These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16767304)

  • 21. Pharmacotherapy for obesity--promise and uncertainty.
    Yanovski SZ
    N Engl J Med; 2005 Nov; 353(20):2187-9. PubMed ID: 16291989
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of antiobesity medications in patients with type 2 diabetes mellitus.
    Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS
    Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug treatment of obesity].
    Burniat W
    Rev Med Brux; 2009; 30(2):124-6. PubMed ID: 19517912
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacotherapy for obesity.
    Halford JC
    Appetite; 2006 Jan; 46(1):6-10. PubMed ID: 16229924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity.
    Gray LJ; Cooper N; Dunkley A; Warren FC; Ara R; Abrams K; Davies MJ; Khunti K; Sutton A
    Obes Rev; 2012 Jun; 13(6):483-98. PubMed ID: 22288431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic treatment of obesity.
    Sidhaye A; Cheskin LJ
    Adv Psychosom Med; 2006; 27():42-52. PubMed ID: 16418541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
    Ryan DH
    Endocrine; 2000 Oct; 13(2):193-9. PubMed ID: 11186220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents.
    García Díaz E; Martín Folgueras T
    Nutr Hosp; 2011; 26(3):451-7. PubMed ID: 21892560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
    Richter WO
    MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort.
    Douglas IJ; Bhaskaran K; Batterham RL; Smeeth L
    Br J Clin Pharmacol; 2015 Jun; 79(6):1020-7. PubMed ID: 25641659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for obesity.
    Neff LM; Aronne LJ
    Curr Atheroscler Rep; 2007 Dec; 9(6):454-62. PubMed ID: 18377785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review.
    Neovius M; Narbro K
    Int J Obes (Lond); 2008 Dec; 32(12):1752-63. PubMed ID: 18982009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rimonabant for the treatment of overweight and obese people.
    Burch J; McKenna C; Palmer S; Norman G; Glanville J; Sculpher M; Woolacott N
    Health Technol Assess; 2009 Oct; 13 Suppl 3():13-22. PubMed ID: 19846024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy to reduce visceral fat.
    Blackburn GL; Waltman BA
    Clin Cornerstone; 2005; 7(2-3):52-60. PubMed ID: 16473261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New drugs for the treatment of obesity].
    Mustajoki P
    Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis.
    Sabuncu T; Nazligul Y; Karaoglanoglu M; Ucar E; Kilic FB
    Rom J Gastroenterol; 2003 Sep; 12(3):189-92. PubMed ID: 14502318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety.
    Glazer G
    Arch Intern Med; 2001 Aug 13-27; 161(15):1814-24. PubMed ID: 11493122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological management of obesity.
    Hanif MW; Kumar S
    Expert Opin Pharmacother; 2002 Dec; 3(12):1711-8. PubMed ID: 12472368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Currently available drugs for the treatment of obesity: Sibutramine and orlistat.
    Chaput JP; St-Pierre S; Tremblay A
    Mini Rev Med Chem; 2007 Jan; 7(1):3-10. PubMed ID: 17266632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.